logo
‘My husband's diabetes destroyed our sex life – here's how we saved our marriage'

‘My husband's diabetes destroyed our sex life – here's how we saved our marriage'

Yahoo13 hours ago
'Sex – several times a week – had always been an important glue in our marriage,' says Sara Chaudary, who's been with her husband Arion for 17 years. 'Yet there were horribly strained evenings, when we'd start having sex but couldn't finish. As a result he stopped instigating sex, and rejected me trying to start it. This just wasn't the norm for us.'
Erectile dysfunction (ED) – the inability to get or maintain an erection sufficient for satisfactory sexual performance – remains one of the most awkwardly unspoken medical conditions among men. Yet for millions worldwide, it is far from rare – especially when diabetes is thrown into the mix. For West Yorkshire restaurant owners Sara, 36, and Arion, 45, problems in the bedroom followed shortly after Arion's Type 2 diabetes diagnosis at the age of 43.
He is not alone. In the UK, more than 4.3 million people live with diabetes, with around 90 per cent of cases being Type 2, like Arion's. According to Diabetes UK, ED is more likely in older men with Type 2 diabetes and those living with obesity, though it can affect men of any age with any type of diabetes. Up to 75 per cent of men suffering from diabetes will experience some degree of ED over their lifetime, with male diabetics thought to develop symptoms 10-15 years earlier than other men.
'It's one of the most common complications of the disease – yet it's also one of the least discussed,' says consultant urologist Professor David Ralph, of University College London.
'Many men feel embarrassed when I meet them, the term 'erectile dysfunction' rarely leave their lips. Instead they come in saying things like, 'it's not like it used to be, doctor' or 'it's not working properly down there'. There's often a feeling that they've somehow let themselves or their partner down,' says Professor Ralph.
'It's my job to explain that ED is extremely common – particularly with age and underlying health conditions like diabetes – and that it's a medical issue, not a personal failing.'Why this occurs, says Professor Ralph, is because prolonged high blood sugar can damage the small blood vessels and nerves which are essential for an erection. 'This reduces blood flow and sensation in the penis. Men with diabetes are also more likely to have low testosterone, which further lowers sexual desire,' he adds.
Professor Ralph also points out that psychological factors such as anxiety or low mood can worsen the problem. While other diabetes-related health problems, such as heart or kidney disease, may also play a role in reducing sexual desire and contributing to erection problems.
Sara and Arion first met in 2008, moved in together within two months and welcomed their first child a year later. But their whirlwind romance stood the test of time, as they married and went on to have five sons together, now aged 16, 14, 12, nine and three.
'After so many years together we both know sex isn't the be-all and end-all, but it's certainly the important glue, and I'd say we connected this way three to four times a week' says Sara, who helps run Arion's restaurant. 'Having friends who haven't had passion that actually lasts, we always felt very fortunate in that area.'
A routine check-up a few years ago showed Arion was pre-diabetic. 'Diabetes is more prevalent in the South East Asian community, and in my line of work I'm constantly surrounded by delicious chapatis, naan, and we cook with ghee – admittedly not ideal for insulin levels,' he says.
According to Professor Ralph, pre-diabetes is a 'warning sign' and prompt action – modifying lifestyle factors such as weight loss – can minimise the risks by getting the sugars controlled.
Determined to reverse the condition naturally, Arion improved his diet, installed a treadmill in the front room, and played football with his sons. But despite these efforts, by 43, he'd tipped into full Type 2 diabetes. This too, alas, is common says Professor Ralph. 'Many patients progress to full blown diabetes, and all of the cardiovascular complications including ED.'
That's when things started to change in the bedroom.
'For someone who is naturally full of beans, Arion became more lethargic,' describes Sara. 'His erections were weaker, and intercourse became a struggle.'
Sara admits she worried Arion had stopped finding her attractive. 'After five babies my body had changed, however many kegel exercises I did. There were tense evenings, and the longer it carried on, the more Arion lost his confidence. His enthusiasm for sex waned, I'm sure he feared it would result in failure.' She knew they needed to talk about it – but not during sex.
'I didn't want to bring it up while in bed, with all that pressure. So instead, the two of us we went out for a walk and I said, 'I love you, come on, let's talk about this.' Arion seemed relieved I'd raised it. 'Of course I still fancy you,' he reassured me. And I cried, 'Of course I don't think you're letting me down.' That initial conversation was an important first step.
Together, they focused on non-penetrative ways to stay intimate. 'We tried massages, different positions, using sex toys, and yes – forgive me if this is frank – we practised more oral sex,' admits Sara says. 'It was worth us both improving our technique, and just lightening up a little if things didn't work out.'
When Arion decided he wasn't ready to stop having sex in the way they were used to, he went to the GP, who suggested Viagra.
PDE5 inhibitor oral medications – like sildenafil (Viagra) or tadalafil (Cialis) – remain the first-line treatment according to Professor Ralph. These work by temporarily improving blood flow.
'However, they don't address another key issue that many men with ED face – the problem of blood leaking back out too quickly, which can make it hard to maintain an erection. Studies indicate that around half of men stop taking them within a year. Patients often report side effects like headaches or flushing and do not like having to plan sex around a pill.'
Treatments for ED have advanced considerably, says Professor Ralph, with far more available today than 10 years ago.Second-line options include NHS-provided mechanical vacuum devices, which help draw blood back into the penis. 'While these are effective and non-invasive, many men find them inconvenient or uncomfortable long-term,' admits Professor Ralph.
Penile injections are another alternative. 'Alprostadil injections (which relax the blood vessels in the penis) are used when oral treatments fail and are effective in the majority of cases, but drawbacks include pain, priapism risk (an unwanted erection lasting hours), and the need for self-injection,' says Professor Ralph.
Penile implants are available too, but this surgical option tends to be reserved for more complex or persistent cases. They're irreversible but associated with high satisfaction rates.
'More recently, there's been growing interest in treatments that aim to restore function more naturally – especially among men (such as Arion) who want longer-term solutions or don't like the idea of planning sex around a pill.'
One example is low-intensity shockwave therapy which is a private treatment that uses sound waves to stimulate blood flow and encourage new blood vessel growth.
'It can benefit some, particularly those with mild ED, but the clinical results are mixed, and it requires multiple clinic visits, and can cost up to £3000,' explains Professor Ralph.
'Another option is Vertica, a handheld, at-home device, using radiofrequency energy to improve blood flow and reduce venous leak, a common cause of ED,' he adds.
A peer reviewed study in the International Journal of Impotence Research reported that 85 per cent of users experienced improvement at four weeks, and 93 per cent had erections sufficient for penetration by 12 weeks.
It's approved by the MHRA (Medicines and Healthcare products Regulatory Agency) though is not available on the NHS and costs approximately £1,250-£1,500, depending on the model.Interestingly, says Professor Ralph, the device worked just as well in men with diabetes 'who are typically harder to treat'. 'Around 40 per cent of men in the trial had Type 2 diabetes – given how often ED and diabetes go hand in hand that's encouraging.'
For Arion personally, 'who doesn't even like taking paracetamol' it was the drug free solution, Vertica, that worked. 'After about a month of using the device three to four times a week consistently we noticed a difference,' says Arion. 'My morning erections returned, full sex was mostly possible, and crucially my confidence improved,' says Arion. 'It felt like turning back time in a way we didn't think possible.'Today, the couple feel closer than ever. 'It's just like normal again, before his diabetes diagnosis,' Sara says. 'We laugh more, talk more, touch more. We came through this hurdle together, and who knows, we're not ruling out baby number six in the future...'
Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

UK Government to introduce new digital system for NHS
UK Government to introduce new digital system for NHS

Yahoo

time18 minutes ago

  • Yahoo

UK Government to introduce new digital system for NHS

The UK Government has announced a strategy to expedite technology access across the National Health Service (NHS) with a new digital system. This initiative aims to reduce bureaucratic challenges and enhance life science through a streamlined process. The forthcoming 'innovator passport', set to launch over the next two years, will enable technologies assessed by one NHS organisation to be implemented by others. This is a focal point of the government's Plan for Change and its ten-year vision for health, which seeks to shape an NHS that is ready for the future. Complex procedures and slow approval times have previously deterred businesses from engaging with the NHS. The new system is set to eliminate these barriers, enabling organisations to collaborate with the NHS. A 'one-stop shop' thorough check will allow businesses to promptly commence operations across the nation. NHS patients will therefore benefit from quicker access to more effective treatments and support. The 'innovator passport' will eliminate the need for multiple compliance assessments, lessening redundancy within the health service. MedTech Compass, a digital platform developed by the Department of Health and Social Care (DHSC), will facilitate the delivery of the passport. Health and Social Care Secretary of State Wes Streeting said: 'These innovator passports will save time and reduce duplication, meaning our life sciences sector, a central part of our 10-Year Health Plan, can work hand-in-hand with the health service and make Britain a powerhouse for medical technology.' This platform will also support the Life Sciences Sector Plan, part of the industrial strategy designed to improve Britain's life sciences sector. Once a healthcare tool is evaluated by one NHS organisation, other organisations will no longer require repeated assessments, allowing local systems to conserve resources previously spent on duplicative bureaucratic processes. "UK Government to introduce new digital system for NHS" was originally created and published by Hospital Management, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.

Enrolment concludes in Belite Bio's trial of Tinlarebant for geographic atrophy
Enrolment concludes in Belite Bio's trial of Tinlarebant for geographic atrophy

Yahoo

time3 hours ago

  • Yahoo

Enrolment concludes in Belite Bio's trial of Tinlarebant for geographic atrophy

Belite Bio has completed enrolment in the 24-month PHOENIX Phase III trial assessing the tolerability and safety of oral Tinlarebant in individuals with geographic atrophy (GA) in dry age-related macular degeneration (AMD). This multicentre, randomised, placebo-controlled, double-masked, global trial is crucial in evaluating the therapy's potential to minimise the atrophic lesion growth rate in these patients. It has enrolled 500 participants across various sites in the US, the UK, the Czech Republic, France, Switzerland, Taiwan, Australia, and China. Tinlarebant, a one-daily tablet, is being developed as an early intervention to preserve retinal tissue health and integrity in those with Stargardt disease type 1 (STGD1) and GA. At present, there are no treatments approved by the Food and Drug Administration (FDA) for STGD1 and no approved oral treatments for GA. The tablet has received fast track, rare paediatric disease, and breakthrough therapy designations in the US, orphan drug status in the US, Japan, and Europe, and Sakigake designation in Japan for STGD1. Tinlarebant is also being evaluated in a Phase III trial (DRAGON) and a Phase II/III trial (DRAGON II) for adolescent STGD1 individuals, in addition to the PHOENIX trial for GA subjects. Belite Bio CEO and chairman Dr Tom Lin said: 'Completing enrolment in the PHOENIX trial marks an important milestone for Belite Bio as we advance our lead candidate, Tinlarebant, for the treatment of geographic atrophy. 'This achievement brings us one step closer to evaluating the potential of Tinlarebant to slow atrophic lesion growth in this serious and progressive disease for which there are no approved oral treatments. There remains a significant unmet need for this patient population.' The company develops new treatments for degenerative retinal diseases like STGD1 and GA. Last year, the company submitted an application to the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) to initiate a trial of Tinlarebant for adolescent STGD1 treatment. "Enrolment concludes in Belite Bio's trial of Tinlarebant for geographic atrophy" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio

Ministers face backbench calls to widen access to top tier of sickness benefits
Ministers face backbench calls to widen access to top tier of sickness benefits

Yahoo

time3 hours ago

  • Yahoo

Ministers face backbench calls to widen access to top tier of sickness benefits

Ministers are facing Labour backbench calls to widen access to their proposed top tier of sickness benefits. Labour backbencher Graeme Downie has proposed a welfare reform Bill amendment, so universal credit claimants with Parkinson's or multiple sclerosis who cannot work do not face repeated medical assessments to receive a payout. If MPs back his amendment, patients with 'evolving' needs who cannot work could also qualify for a higher rate of benefits. The Government's Bill has already cleared its first Commons hurdle at second reading, after work and pensions minister Sir Stephen Timms vowed not to restrict eligibility for the personal independence payment (Pip), with any changes coming in only after a review of the benefit. To meet his promise, ministers have had to table amendments to their own draft new law, to remove one of its seven clauses, which MPs will debate next Wednesday. Universal credit claimants with Parkinson's 'are already possibly struggling financially', Mr Downie told the PA news agency ahead of the debate. He added: 'The cost of living with a condition like Parkinson's can be very high. 'You may well require or need additional support.' The Dunfermline and Dollar MP said patients who struggle with their motor control might buy pre-chopped vegetables or chicken. 'Those things are expensive, so if you're already on universal credit and you're struggling, being able to do that significantly impacts your health, it significantly impacts your ability to live properly,' he continued. As part of the Government's reforms, the Department for Work and Pensions has proposed a new 'severe conditions criteria' for universal credit. Claimants in this category will be entitled to a higher rate of the benefit, and will not be routinely reassessed to receive money. To qualify, claimants must have limited capability for work or work-related activity (LCWRA) and symptoms which 'constantly' apply. Mr Downie's amendment would expand these criteria to claimants with 'a fluctuating condition'. It would cover 'conditions like Parkinson's but also multiple sclerosis, ME (myalgic encephalomyelitis), long Covid and a whole range of other conditions where, you know, in the morning things could be really good and in the afternoon things could be really bad, and even hour by hour things could change', he said. 'I felt it was necessary to table an amendment to really probe what the Government's position is on this, and ensuring that people with Parkinson's and conditions like that are not excluded from even applying and being considered.' Mr Downie's proposal has backing from 23 cross-party MPs. Juliet Tizzard, external relations director at Parkinson's UK, said: 'Criteria in the Bill say that a new claimant for the universal credit health payment will have to be 'constantly' unable to perform certain activities to qualify. 'This doesn't work for people with Parkinson's, whose symptoms change throughout the day. 'People with Parkinson's and other fluctuating conditions like multiple sclerosis will be effectively excluded from getting all the financial support they need. 'The Government has responded to our call and withdrawn the damaging restrictions to Pip. 'Now, they must do the same with the universal credit health element. The health of many people with Parkinson's is in their hands.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store